Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

PPROVECTUS BIOPHARMACEUTICALS, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
P

PROVECTUS BIOPHARMACEUTICALS, INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Oct 3, 2026Pershing EdwardCEO13,216Series D-1 Convertible Preferred Stock—Exercise / conversion
Oct 3, 2026Pershing EdwardCEO—8% Unsecured Convertible Promissory Note—Exercise / conversion
Sep 18, 2026Pershing EdwardCEO13,216Series D-1 Convertible Preferred Stock—Exercise / conversion
Sep 18, 2026Pershing EdwardCEO—8% Unsecured Convertible Promissory Note—Exercise / conversion
Sep 11, 2026Pershing EdwardCEO13,216Series D-1 Convertible Preferred Stock—Exercise / conversion
Sep 11, 2026Pershing EdwardCEO—8% Unsecured Convertible Promissory Note—Exercise / conversion
Sep 4, 2026Pershing EdwardCEO11,328Series D-1 Convertible Preferred Stock—Exercise / conversion
Sep 4, 2026Pershing EdwardCEO—8% Unsecured Convertible Promissory Note—Exercise / conversion
Aug 26, 2026Pershing EdwardCEO11,328Series D-1 Convertible Preferred Stock—Exercise / conversion
Aug 26, 2026Pershing EdwardCEO—8% Unsecured Convertible Promissory Note—Exercise / conversion
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions